Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 42.

Oebel, S; Hamada, S; Higashigaito, K; von Spiczak, J; Klotz, E; Enseleit, F; Hinzpeter, R; Ruschitzka, F; Manka, R; Alkadhi, H (2018). Comprehensive morphologic and functional imaging of heart transplant patients: first experience with dynamic perfusion CT. European Radiology:Epub ahead of print.

Naegele, M; Flammer, A J; Enseleit, F; Roas, S; Frank, M; Hirt, A; Kaiser, P; Cantatore, S; Templin, C; Fröhlich, G; Romanens, M; Lüscher, T F; Ruschitzka, F; Noll, G; Sudano, I (2016). Endothelial function and sympathetic nervous system activity in patients with Takotsubo syndrome. International Journal of Cardiology, 224:226-230.

Rizzi, G; Startseva, X; Wolfrum, M; Lüscher, T F; Ruschitzka, F; Fröhlich, G M; Enseleit, F (2016). Unfavorable Donor Pretransplant APACHE II, SAPS II, and SOFA Scores Are Not Associated With Outcome: Implications for Heart Transplant Donor Selection. Transplantation Proceedings, 48(8):2582-2587.

Reser, D; Fröhlich, G M; Seifert, Burkhardt; Lachat, Mario L; Jacobs, S; Enseleit, F; Ruschitzka, F; Falk, V; Wilhelm, M J (2014). The impact of pretransplantation urgency status and the presence of a ventricular assist device on outcome after heart transplantation. Transplantation Proceedings, 46(5):1463-1468.

Raess, M; Frohlich, G; Roos, Malgorzata; Rusi, B; Wilhelm, M J; Noll, G; Ruschitzka, F; Fehr, T; Enseleit, F (2013). Donor-specific anti-HLA antibodies detected by Luminex: predictive for short-term but not long-term survival after heart transplantation. Transplant International, 26(11):1097-1107.

Frohlich, G M; Keller, P; Schmid, F; Wolfrum, M; Osranek, M; Falk, C; Noll, G; Enseleit, F; Reinthaler, M; Meier, P; Luscher, T F; Ruschitzka, F; Tanner, F C (2013). Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure. European Heart Journal, 34(19):1414-1423.

Winnik, S; Lohmann, C; Siciliani, G; von Lukowicz, T; Kuschnerus, K; Kraenkel, N; Brokopp, C E; Enseleit, F; Michels, S; Ruschitzka, F; Luscher, T F; Matter, C M (2013). Systemic VEGF inhibition accelerates experimental atherosclerosis and disrupts endothelial homeostasis - implications for cardiovascular safety. International Journal of Cardiology, 168(3):2453-2461.

Flammer, A J; Sudano, I; Wolfrum, M; Thomas, R; Enseleit, F; Périat, D; Kaiser, P; Hirt, A; Hermann, M; Serafini, M; Lévêques, A; Lüscher, T F; Ruschitzka, F; Noll, G; Corti, R (2012). Cardiovascular effects of flavanol-rich chocolate in patients with heart failure. European Heart Journal, 33(17):2172-2180.

Sudano, I; Flammer, A J; Roas, S; Enseleit, F; Ruschitzka, F; Corti, R; Noll, G (2012). Cocoa, blood pressure, and vascular function. Current Hypertension Reports, 14(4):279-284.

Sudano, I; Flammer, A J; Roas, S; Enseleit, F; Noll, G; Ruschitzka, F (2012). Nonsteroidal antiinflammatory drugs, acetaminophen, and hypertension. Current Hypertension Reports, 14(4):304-309.

Enseleit, F; Sudano, I; Ghadri, J R; Templin, C (2012). Takotsubo Kardiomyopathie: Eine wichtige Differentialdiagnose des Akuten Koronarsyndroms. Cardiovascular Medicine, 15(11):310-316.

Hermann, M; Enseleit, F; Fisler, A E; Flammer, A; Lüscher, T F; Noll, G; Ruschitzka, F (2011). Cyclosporine C0- versus C2-monitoring over three years in maintenance heart transplantation. Swiss Medical Weekly, 141:w13149.

Enseleit, F; Ruschitzka, F (2011). Is there a link between angiotensin receptor blockers and cancer? Current Hypertension Reports, 13(1):5-7.

Stähli, B E; Ruschitzka, F; Enseleit, F (2011). Isolated right ventricular ballooning syndrome: a new variant of transient cardiomyopathy. European Heart Journal, 32(14):1821.

Toggweiler, S; Borst, O; Enseleit, F; Hermann, M; Ruschitzka, F; Lüscher, T F; Noll, G (2011). NT-proBNP provides incremental prognostic information in cardiac outpatients with and without echocardiographic findings. Clinical Cardiology, 34(3):183-188.

Enseleit, F; Kretschmar, O; Lüscher, T F (2010). Percutaneous implantation of an ASD occluder with intracardiac ultrasound. Cardiovascular Medicine, 13(9):290-291.

Sudano, I; Flammer, A J; Périat, D; Enseleit, F; Hermann, M; Wolfrum, M; Hirt, A; Kaiser, P; Hurlimann, D; Neidhart, M; Gay, S; Holzmeister, J; Nussberger, J; Mocharla, P; Landmesser, U; Haile, S R; Corti, R; Vanhoutte, P M; Lüscher, T F; Noll, G; Ruschitzka, F (2010). Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation, 122(18):1789-1796.

Sudano, I; Farshad, M; Flammer, A J; Spieker, L; Periat, D; Enseleit, F (2010). Acute effect of nitroglycerin on cyclosporine-induced hypertension after cardiac transplantation. Swiss Medical Weekly, 140(9-10):139-145.

Enseleit, F; Michels, S; Ruschitzka, F (2010). Anti-VEGF therapies and blood pressure: more than meets the eye. Current Hypertension Reports, 12(1):33-38.

Enseleit, F; Ruschitzka, F (2010). Darusentan in resistant hypertension: lost in translation. Current Hypertension Reports, 12(1):1-3.

Enseleit, F; Lüscher, T F; Ruschitzka, F (2010). Darusentan, a selective endothelin A receptor antagonist, for the oral treatment of resistant hypertension. Therapeutic Advances in Cardiovascular Disease, 4(4):231-240.

Enseleit, F; Ruschitzka, F; Noll, G (2010). Diagnostik und medikamentöse Therapie der Herzinsuffizienz: Der Hausarzt stellt wichtige Weichen. Hausarzt Praxis, 5:7-9.

Enseleit, F; Grünenfelder, J; Braun, J; Matthews, F; Jenni, R; van der Loo, B (2010). Formation of pseudoaneurysm after aortic valve replacement without previous endocarditis: a case-control study. Journal of the American Society of Echocardiography, 23(7):741-746.

Enseleit, F (2010). Fortschritte im Kampf gegen die „Epidemie des 21. Jahrhunderts“. Hausarzt Praxis, 5:6.

Fröhlich, G; Steffel, J; Hürlimann, D; Enseleit, F; Lüscher, T F; Ruschitzka, F; Abraham, W T; Holzmeister, J (2010). Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling. European Heart Journal, 31(12):1477-1485.

Enseleit, F; Toggweiler, S; Luscher, T F (2009). Akute Herzinsuffizienz: Medical Nemesis der neuen Art? Kardiovaskuläre Medizin, 12(11):291-293.

Enseleit, F; Ruschitzka, F (2009). The BEAUTIFUL study: is heart rate reduction a new therapeutic principle? Current Hypertension Reports, 11(1):45-47.

Hermann, F; Enseleit, F; Spieker, L; Periat, D; Sudano, I; Hermann, M; Corti, R; Noll, G; Ruschitzka, F; Luscher, T F (2009). Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemia. Thrombosis Research, 123(3):460-465.

Amstein, R; Enseleit, F; Lüscher, T F (2009). 5. «Cardiovascular Roundtable». Schweizerische Ärztezeitung, 90(9):329.

Amstein, R; Enseleit, F; Luscher, T F (2009). Cardiovascular Roundtable. Kardiovaskuläre Medizin, 12(2):60-64.

Enseleit, F; Ruschitzka, F (2009). Current treatment of age-related macular degeneration, determining the cardiovascular risk. British Journal of Cardiology, 16(Supp 2):3-7.

Enseleit, F; Wyss, C A; van der Loo, B; Grünenfelder, J; Oechslin, E N; Jenni, R (2009). Isolated cleft in the posterior mitral valve leaflet: a congenital form of mitral regurgitation. Clinical Cardiology, 32(10):553-560.

Enseleit, F; Lüscher, T F; Ruschitzka, F (2008). Darusentan: a new perspective for treatment of resistant hypertension? Expert Opinion on Investigational Drugs, 17(8):1255-1263.

Flammer, A J; Sudano, I; Hermann, F; Gay, S; Forster, A; Neidhart, M; Künzler, P; Enseleit, F; Périat, D; Hermann, M; Nussberger, J; Luscher, T F; Corti, R; Noll, G; Ruschitzka, F (2008). Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis. Circulation, 117(17):2262-2269.

Periat, D; Sudano, I; Enseleit, F; Noll, G (2008). Betablocker. In: Enseleit, F; Ruschitzka, F. Koronare Herzerkrankung und Herzinfarkt - Aktuelle Studien zur Sekündärprävention( KHK und Herzinfarkt - Aktuelle Studien zur Sekundärprävention). Bremen: UNI-MED Verlag, 82-88.

Cosentino, F; Hürlimann, D; Delli Gatti, C; Chenevard, R; Blau, N; Alp, N J; Channon, K M; Eto, M; Lerch, P; Enseleit, F; Ruschitzka, F; Volpe, M; Lüscher, T F; Noll, G (2008). Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia. Heart, 94(4):487-492.

Enseleit, F; Mueller, N J; Duru, F; Lachat, Mario L; Noll, G; Ruschitzka, F (2008). Teicoplanin-induced complete AV-block in a heart transplant recipient. Infection, 36(3):291-292.

Enseleit, F; Wyss, C A; Duru, F; Noll, G; Ruschitzka, F (2006). Images in cardiovascular medicine. The blue man: amiodarone-induced skin discoloration. Circulation, 113(5):e63.

Hermann, M; Enseleit, F; Ruschitzka, F T (2005). Anti-inflammatory strategies in hypertension: focus on COX-1 and COX-2. Current Hypertension Reports, 7(1):52-60.

Béchir, M; Enseleit, F; Chenevard, R; Lüscher, T F; Noll, G (2005). Effect of losartan on muscle sympathetic activity and baroreceptor function in systemic hypertension. American Journal of Cardiology, 95(1):129-131.

Bechir, M; Enseleit, F; Chenevard, R; Muntwyler, J; Lüscher, T F; Noll, G (2005). Folic Acid improves baroreceptor sensitivity in hypertension. Journal of Cardiovascular Pharmacology, 45(1):44-48.

Hürlimann, D; Enseleit, F; Ruschitzka, F (2004). Rheumatoide Arthritis, Inflammation und Atherosklerose. Herz, 29(8):760-768.

This list was generated on Sun May 27 23:35:43 2018 CEST.